Vimarsana
Biggest News Aggregation in the World

Page 13 - Lantern Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lantern Pharma Today - Breaking & Trending Today

Lantern Pharma Inc Stock Quote | Stock Price for LTRN | FinancialContent Business Page - Vimarsana News

Lantern Pharma Inc Stock Quote | Stock Price for LTRN | FinancialContent Business Page

FinancialContent fully hosted finance channel

Related Topics:
Lantern Pharma
Lantern Pharma Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report - Vimarsana News

Lantern Pharma Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report

DALLAS, TX / ACCESSWIRE / August 19, 2022 / RedChip Companies will air a new interview on Lantern Pharma Inc. (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial

Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Update - Vimarsana News

Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Update

Lantern Pharma Inc. (NASDAQ:LTRN – Get Rating) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 89,700 shares, a drop of 40.4% from the May 15th total of 150,500 shares. Currently, 1.2% of the shares of the company are short […]

GlobalData Plc: Big Data Crucial for Business Strategy - Vimarsana News

GlobalData Plc: Big Data Crucial for Business Strategy

The global data and analytics market in the pharmaceutical sector was valued at $1.4 billion in 2020...

Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins during Brain Tumor Awareness Month - Vimarsana News

Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins during Brain Tumor Awareness Month

/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...